| Isabel Akaragwe, | |
|
609, Taylor Ave, Annapolis, MD 21401 | |
| (410) 268-5007 | |
| (410) 268-0370 |
| Full Name | Isabel Akaragwe |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 609, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528324803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 24343 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Isabel Akaragwe, 1308 Crawfords Ct, Odenton, MD 21113-2349 Ph: (240) 413-6842 | Isabel Akaragwe, 609, Taylor Ave, Annapolis, MD 21401 Ph: (410) 268-5007 |
News Archive
Gen-Probe's PROGENSA® PCA3 assay can help predict the outcome of initial prostate biopsies in men suspected of having prostate cancer, according to a study of the molecular urine test presented in a scientific poster last week at the 25th annual European Association of Urology (EAU) Congress in Barcelona, Spain.
Cinterion, the global leader in cellular machine-to-machine communication modules and a Gemalto company, and TZ Medical, a leading manufacturer of critical-care medical products, today announced Aera-CT, a lightweight and cost effective mHealth heart arrhythmia monitoring device.
Pfizer Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) has been terminated in connection with the tender offer by its wholly-owned subsidiary, Parker Tennessee Corp., to purchase all outstanding shares of common stock of King Pharmaceuticals, Inc. for $14.25 per share, net to the seller in cash, without interest thereon and subject to any required withholding taxes.
AstraZeneca and Sarah Cannon Research Institute (SCRI), an international leader in advancing therapies for cancer patients through clinical research, today announced that SCRI will lead the clinical development of a novel targeted oncology compound from AstraZeneca.
› Verified 8 days ago
Dr. Lawrence J Krebs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2002 Medical Pkwy, Ste 170, Annapolis, MD 21401 Phone: 410-573-6900 Fax: 410-573-1127 | |
Christie Dunton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy Ste G10, Annapolis, MD 21401 Phone: 443-481-5826 | |
Binal Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 123 Main St, Annapolis, MD 21401 Phone: 410-295-3061 | |
Riyo Rajan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-4157 | |
Jazzmine C Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2601 Riva Rd, Annapolis, MD 21401 Phone: 410-571-2090 Fax: 410-571-2896 | |
Margaret M Thomas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-4229 Fax: 443-481-4842 | |
Matthew Howard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Bay Ridge Rd, Annapolis, MD 21403 Phone: 443-268-7688 Fax: 410-268-4597 |